The European Medicines Agency looks set to recommend conditional marketing approval for the first COVID-19 vaccine early next week after public calls from politicians for a faster decision.
The EMA had scheduled a decision on Pfizer/BioNTech’s BNT162b2 by 29 December “at the latest” but has now brought...







